248 related articles for article (PubMed ID: 25033885)
1. Complementary role of 18F-FDG PET and 123I-ioflupane SPECT in the diagnosis of Lewy body disease.
Jolepalem P; Balon HR; Wong CY; Wu D
J Nucl Med Technol; 2014 Sep; 42(3):233-4. PubMed ID: 25033885
[TBL] [Abstract][Full Text] [Related]
2. 123I-Ioflupane SPECT and 18F-FDG PET Combined Use in the Characterization of Movement and Cognitive Associated Disorders in Neurodegenerative Diseases.
Nuvoli S; Tanda G; Stazza ML; Palumbo B; Frantellizzi V; De Vincentis G; Spanu A; Madeddu G
Curr Alzheimer Res; 2021; 18(3):196-207. PubMed ID: 34102975
[TBL] [Abstract][Full Text] [Related]
3. Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
Chiba Y; Iseki E; Fujishiro H; Ota K; Kasanuki K; Suzuki M; Hirayasu Y; Arai H; Sato K
Psychiatry Res Neuroimaging; 2016 Mar; 249():105-12. PubMed ID: 26857415
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET and perfusion SPECT in the diagnosis of Alzheimer and Lewy body dementias.
O'Brien JT; Firbank MJ; Davison C; Barnett N; Bamford C; Donaldson C; Olsen K; Herholz K; Williams D; Lloyd J
J Nucl Med; 2014 Dec; 55(12):1959-65. PubMed ID: 25453043
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic Alertness Is Impaired in Patients with Nigrostriatal Degeneration: A Prospective Study with Reference to [123I]FP-CIT SPECT and [18F]FDG PET.
Frings L; Heimbach B; Meyer PT; Hellwig S
J Alzheimers Dis; 2020; 78(4):1721-1729. PubMed ID: 33216022
[TBL] [Abstract][Full Text] [Related]
6. The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies.
Lim SM; Katsifis A; Villemagne VL; Best R; Jones G; Saling M; Bradshaw J; Merory J; Woodward M; Hopwood M; Rowe CC
J Nucl Med; 2009 Oct; 50(10):1638-45. PubMed ID: 19759102
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and
Kobayashi S; Makino K; Hatakeyama S; Ishii T; Tateno M; Iwamoto T; Tsujino H; Kawasaki K; Mikuni K; Ukai W; Murayama T; Hashimoto E; Utsumi K; Kawanishi C
Psychogeriatrics; 2017 Jul; 17(4):247-255. PubMed ID: 28130808
[TBL] [Abstract][Full Text] [Related]
8. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
[TBL] [Abstract][Full Text] [Related]
9. Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques?
Treglia G; Cason E; Cortelli P; Gabellini A; Liguori R; Bagnato A; Giordano A; Fagioli G
J Neuroimaging; 2014; 24(2):149-54. PubMed ID: 23163913
[TBL] [Abstract][Full Text] [Related]
10. Undetectable specific striatal [¹²³I]-ioflupane binding in patients with parkinsonism.
Petyt G; Kreisler A; Demailly F; Olivier A; Defebvre L; Semah F
J Neurol Sci; 2014 Jun; 341(1-2):167-71. PubMed ID: 24814162
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET assessment of Lewy body dementia with cerebellar diaschisis.
Al-Faham Z; Zein RK; Wong CY
J Nucl Med Technol; 2014 Dec; 42(4):306-7. PubMed ID: 25190733
[TBL] [Abstract][Full Text] [Related]
12. Clinical validity of presynaptic dopaminergic imaging with
Sonni I; Ratib O; Boccardi M; Picco A; Herholz K; Nobili F; Varrone A;
Neurobiol Aging; 2017 Apr; 52():228-242. PubMed ID: 28317651
[TBL] [Abstract][Full Text] [Related]
13. Reduced 123I Ioflupane Binding in Bilateral Diabetic Chorea: Findings With 18F FDG PET, 99mTc ECD SPECT, and 123I MIBG Scintigraphy.
Sato K; Hida A; Kameyama M; Morooka M; Takeuchi S
Clin Nucl Med; 2016 Jun; 41(6):481-2. PubMed ID: 26975011
[TBL] [Abstract][Full Text] [Related]
14. Update on SPECT and PET in parkinsonism - part 2: biomarker imaging of cognitive impairment in Lewy-body diseases.
Meyer PT; Frings L; Hellwig S
Curr Opin Neurol; 2014 Aug; 27(4):398-404. PubMed ID: 24978635
[TBL] [Abstract][Full Text] [Related]
15. A new visual rating scale for Ioflupane imaging in Lewy body disease.
Lloyd JJ; Petrides G; Donaghy PC; Colloby SJ; Attems J; O'Brien JT; Roberts G; Thomas AJ
Neuroimage Clin; 2018; 20():823-829. PubMed ID: 30268991
[TBL] [Abstract][Full Text] [Related]
16. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
[TBL] [Abstract][Full Text] [Related]
17. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
[TBL] [Abstract][Full Text] [Related]
18. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
[TBL] [Abstract][Full Text] [Related]
19. Combining 123I-metaiodobenzylguanidine SPECT/CT and 18F-FDG PET/CT for the assessment of brown adipose tissue activity in humans during cold exposure.
Admiraal WM; Holleman F; Bahler L; Soeters MR; Hoekstra JB; Verberne HJ
J Nucl Med; 2013 Feb; 54(2):208-12. PubMed ID: 23318291
[TBL] [Abstract][Full Text] [Related]
20. 11C-DTBZ and 18F-FDG PET measures in differentiating dementias.
Koeppe RA; Gilman S; Joshi A; Liu S; Little R; Junck L; Heumann M; Frey KA; Albin RL
J Nucl Med; 2005 Jun; 46(6):936-44. PubMed ID: 15937303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
